Indivior PLC (INDV)
32.97
-0.57 (-1.70%)
Inactive · Last trade price on Jan 23, 2026
Indivior Employees
Indivior had 1,000 employees as of June 30, 2025. The number of employees did not change compared to the same quarter last year.
Employees
1,000
Change
n/a
Growth
n/a
Revenue / Employee
$1,180,000
Profits / Employee
$124,000
Market Cap
4.12B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Sep 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Jun 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Mar 31, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Sep 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Jun 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Mar 31, 2023 | 1,000 | 200 | 25.00% | 1,000 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Sep 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Jun 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Mar 31, 2022 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Sep 30, 2021 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
INDV News
- 1 day ago - Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th - GlobeNewsWire
- 10 days ago - New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities - GlobeNewsWire
- 24 days ago - National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder - GlobeNewsWire
- 4 weeks ago - Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering - GlobeNewsWire
- 4 weeks ago - Indivior Announces Proposed Convertible Senior Notes Offering - GlobeNewsWire
- 4 weeks ago - New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder - GlobeNewsWire
- 6 weeks ago - Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Indivior to Participate in Upcoming Investor Conferences - GlobeNewsWire